| 1 |
Hiyoshi Y, Daitoku N, Mukai T, Nagasaki T, Yamaguchi T, Akiyoshi T, Yasue C, Chino A, Saito S, Takamatsu M, Fukunaga Y. Risk Factors for Lymph Node Metastasis of Rectal Neuroendocrine Tumor and Its Prognostic Impact: A Single-Center Retrospective Analysis of 195 Cases with Radical Resection. Ann Surg Oncol 2023. [PMID: 36935432 DOI: 10.1245/s10434-023-13348-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 2 |
马 明. Advances in Epidemiology, Diagnostics and Drug Treatment of Pancreatic Neuroendocrine Neoplasm. ACM 2023;13:1849-1859. [DOI: 10.12677/acm.2023.132256] [Reference Citation Analysis]
|
| 3 |
Zhuang X, Zhang S, Chen G, Luo Z, Hu H, Huang W, Guo Y, Ouyang Y, Peng L, Qing Q, Chen H, Li B, Chen J, Wang X. Risk factors and clinical outcomes of incomplete endoscopic resection of small rectal neuroendocrine tumors in southern China: a 9-year data analysis. Gastroenterol Rep (Oxf) 2023;11:goac084. [PMID: 36632622 DOI: 10.1093/gastro/goac084] [Reference Citation Analysis]
|
| 4 |
Imamura M, Komoto I, Taki Y. How to treat gastrinomas in patients with multiple endocrine neoplasia type1: surgery or long-term proton pump inhibitors? Surg Today 2022. [DOI: 10.1007/s00595-022-02627-z] [Reference Citation Analysis]
|
| 5 |
Tamura T, Sugihara Y, Yamazaki H, Koutani H, Tamura T, Tsuda I, Emori T, Kawaji Y, Hatamaru K, Yamashita Y, Itonaga M, Ashida R, Kitano M. Contrast-Enhanced Harmonic Endoscopic Ultrasound for Diagnosis of the Aggressiveness of Pancreatic Neuroendocrine Neoplasm. Diagnostics (Basel) 2022;12. [PMID: 36552995 DOI: 10.3390/diagnostics12122988] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Mizuno Y, Ito T, Ueda K, Tashiro A, Kubota Y, Yamashita A, Miura M, Hayama H, Oya M, Tsuneyoshi M. A case of erythema multiforme-like rash induced by everolimus in a patient with a pancreatic neuroendocrine tumor. Clin J Gastroenterol 2022. [PMID: 36264476 DOI: 10.1007/s12328-022-01709-2] [Reference Citation Analysis]
|
| 7 |
Yamamoto S, Sakakibara N, Hirano H, Morizane C, Honma Y, Hijioka S, Okusaka T, Higashi T, Kawai A. The real-world selection of first-line systemic therapy regimen for metastatic gastroenteropancreatic neuroendocrine neoplasm in Japan. Sci Rep 2022;12:17601. [PMID: 36266484 DOI: 10.1038/s41598-022-22718-8] [Reference Citation Analysis]
|
| 8 |
Liu Y, Zhao X, Zhang J, Wang J, Zhang Z, Dai M, Wang N, Jing F, Wang T, Tian W. 68Ga-DOTATATE PET/CT imaging for insulinoma in MEN1 patient with endogenous hyperinsulinemic hypoglycemia: A case report. Medicine (Baltimore) 2022;101:e30252. [PMID: 36042606 DOI: 10.1097/MD.0000000000030252] [Reference Citation Analysis]
|
| 9 |
Sekiguchi M, Hotta K, Takeuchi Y, Tanaka S, Yamamoto H, Shinmura K, Harada K, Uraoka T, Hisabe T, Sano Y, Kondo H, Horimatsu T, Kikuchi H, Kawamura T, Nagata S, Yamamoto K, Tajika M, Tsuji S, Kusaka T, Okuyama Y, Yoshida N, Moriyama T, Hasebe A, So S, Kobara H, Kashida H, Miyanaga R, Kato S, Hayashi Y, Sada M, Fukuzawa M, Kato H, Takayama T, Konishi J, Matsushita HO, Narasaka T, Ohata K, Togashi K, Nakamura H, Moriichi K, Oda Y, Kanda N, Kuwai T, Terai S, Sanomura M, Kitamura S, Miyamoto H, Kiriyama S, Mizuno C, Saito Y, Sekine S, Ito S, Nakahira H, Oka S, Hayashi Y, Yoshimura K, Ishikawa H, Matsuda T; C-NET STUDY Group. Characteristics of colorectal neuroendocrine tumors in patients prospectively enrolled in a Japanese multicenter study: a first report from the C-NET STUDY. J Gastroenterol 2022;57:547-58. [PMID: 35554678 DOI: 10.1007/s00535-022-01877-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 10 |
Karlafti E, Charalampidou M, Fotiadou G, Abba Deka I, Raptou G, Kyriakidis F, Panidis S, Ioannidis A, Protopapas AA, Netta S, Paramythiotis D. Ampullary Large-Cell Neuroendocrine Carcinoma, a Diagnostic Challenge of a Rare Aggressive Neoplasm: A Case Report and Literature Review. Diagnostics 2022;12:1797. [DOI: 10.3390/diagnostics12081797] [Reference Citation Analysis]
|
| 11 |
Takeda Y, Kobayashi N, Kessoku T, Okubo N, Suzuki A, Tokuhisa M, Miwa H, Udaka N, Ichikawa Y. Case reports: chemoradiotherapy for locally advanced neuroendocrine carcinoma of the gallbladder. Clin J Gastroenterol 2022. [PMID: 35653037 DOI: 10.1007/s12328-022-01645-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 12 |
Li YL, Cheng ZX, Yu FH, Tian C, Tan HY. Advances in medical treatment for pancreatic neuroendocrine neoplasms. World J Gastroenterol 2022; 28(20): 2163-2175 [DOI: 10.3748/wjg.v28.i20.2163] [Reference Citation Analysis]
|
| 13 |
Yin F, Wu ZH, Lai JP. New insights in diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms. World J Gastroenterol 2022; 28(17): 1751-1767 [DOI: 10.3748/wjg.v28.i17.1751] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 14 |
Kaliszewski K, Ludwig M, Greniuk M, Mikuła A, Zagórski K, Rudnicki J. Advances in the Diagnosis and Therapeutic Management of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs). Cancers (Basel) 2022;14:2028. [PMID: 35454934 DOI: 10.3390/cancers14082028] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
